![discount label](https://static.cymitquimica.com/public/img/discount.png)
Product Information
- LY 3012212, IMC-18F1
Icrucumab ( IMC-18F1) is a humanized IgG1 monoclonal antibody targeting vascular endothelial growth factor receptor-1.Icrucumab has antitumor activity.Icrucumab has been studied in metastatic colon cancer.
Chemical properties
Technical inquiry about: TM-T76866 Icrucumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.